Details of the Drug Combinations

General Information of This Drug (ID: DMWHN3T)

Drug Name

PPADS DMWHN3T

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Artemisinin + PPADS	DCHLY28	Artemisinin	DD2 (Cell Line: DD2)	[2]
Mefloquine + PPADS	DCS0LYF	Mefloquine	DD2 (Cell Line: DD2)	[2]
------------------------------------------------------------------------------------

References

1	Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal. 2009 Mar;5(1):75-89.
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.